BioClinica
Newtown
About BioClinica
BioClinica, Inc. is a leading global provider of integrated, technology-enhanced clinical trial management services. BioClinica supports pharmaceutical and medical device innovation with imaging core lab, internet image transport, electronic data capture, interactive voice and web response, clinical trial management and clinical supply chain design and optimization solutions. BioClinica services maximize efficiency and manageability throughout all phases of the clinical trial process. With more than 20 years of experience and over 2,000 successful trials to date, BioClinica has supported the clinical development of many new medicines from early phase trials through final approval. BioClinica operates state-of-the-art, regulatory-body-compliant imaging core labs on two continents, and supports worldwide eClinical and data management services from offices in the United States, Europe and Asia.
Company Facts
- Operating status: Closed
- Company type: For Profit
- IPO status: Private
- Employees: 1,001 – 5,000
- Estimated revenue: $100K – $500K
- Total funding: $13.7M
- Funding stage: M&A
- Last round: Series Unknown (Jan 2013)
- Website: bioclinica.com
- Phone: 4849286001
Industries & Categories
Biotechnology, Clinical Trials, Medical Device
Social Profiles
Canonical: https://fsome.com/organization/bioclinica-2005529 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.